Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin

Luis A. Marcos, Bernard C. Camins

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.

Original languageEnglish
Pages (from-to)5376-5378
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number12
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin'. Together they form a unique fingerprint.

Cite this